Insiders Updates Understanding the Risks of Investing in Atyr Pharma Inc (LIFE) Atyr Pharma Inc’s recent filing unveils that its Chief Financial Officer Broadfoot Jill Marie unloaded Company’s shares for reported $2687.0
Stock Earnings Atyr Pharma Inc (LIFE) rating downgrades by Oppenheimer Atyr Pharma Inc’s filing revealed that its Chief Financial Officer Broadfoot Jill Marie unloaded Company’s shares for reported $2687.0 on
Stock Earnings A Guide To The Risks Of Investing In Atyr Pharma Inc (LIFE) Atyr Pharma Inc’s recent filing unveils that its Chief Financial Officer Broadfoot Jill Marie unloaded Company’s shares for reported $2687.0